4/11
10:23 am
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $37.00 to $40.00. They now have an "overweight" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $37.00 to $40.00. They now have an "overweight" rating on the stock.
4/10
12:46 pm
insm
What Makes Insmed (INSM) a Lucrative Investment? [Yahoo! Finance]
Low
Report
What Makes Insmed (INSM) a Lucrative Investment? [Yahoo! Finance]
4/5
08:00 am
insm
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4/1
12:17 pm
insm
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $55.00 price target on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $55.00 price target on the stock.
3/27
04:14 pm
insm
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference [Yahoo! Finance]
Low
Report
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference [Yahoo! Finance]
3/27
04:05 pm
insm
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
Low
Report
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
3/5
08:00 am
insm
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
2/29
08:00 am
insm
Insmed To Present at Three March Conferences
Low
Report
Insmed To Present at Three March Conferences
2/28
04:13 pm
insm
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health [Yahoo! Finance]
Low
Report
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health [Yahoo! Finance]
2/28
04:05 pm
insm
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health
Low
Report
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health
2/28
02:05 am
insm
Insmed Incorporated (NASDAQ: INSM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
2/27
01:08 pm
insm
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $52.00 to $54.00. They now have a "buy" rating on the stock.
Low
Report
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Guggenheim from $52.00 to $54.00. They now have a "buy" rating on the stock.
2/27
08:08 am
insm
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $46.00 price target on the stock.
Neutral
Report
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $46.00 price target on the stock.
2/23
12:34 pm
insm
Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/22
09:48 am
insm
Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/22
07:06 am
insm
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
2/22
07:00 am
insm
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
Medium
Report
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
2/20
11:04 pm
insm
Insmed Incorporated (NASDAQ: INSM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/15
07:17 am
insm
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
Medium
Report
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $42.00 price target on the stock.
2/8
08:00 am
insm
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
Low
Report
Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024
2/2
04:05 pm
insm
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Low
Report
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)